Integrative overview of antibodies against SARS-CoV-2 and their possible applications in COVID-19 prophylaxis and treatment
Norma A. Valdez-Cruz, Enrique García-Hernández, Clara Espitia, Laura Cobos-Marín, Claudia Altamirano, Carlos G. Bando-Campos, Luis F. Cofas-Vargas, Enrique W. Coronado-Aceves, Ricardo A. González-Hernández, Pablo Hernández-Peralta, Daniel Juárez-López, Paola A. Ortega-Portilla, Sara Restrepo-Pineda, Patricio Zelada-Cordero & Mauricio A. Trujillo-Roldán
Abril 2021
Ten scientific reasons in support of airborne transmission of SARS-CoV-2
Trisha Greenhalgh, Jose L Jimenez, Kimberly A Prather, Zeynep Tufekci, David Fisman, Robert Schooley
Abril 2021
La radiografía que el SARS-CoV-2 nos da de la sociedad
Consejo Interno del Centro de Ciencias de la Complejidad
Agosto 2020
Is the kidney a target of SARS-CoV-2?
Miguel Angel Martinez-Rojas, Olynka Vega-Vega, and Norma A. Bobadilla
American Journal of Physiology
Mayo 2020
The Risks – Know Them – Avoid Them
Professor Erin Bromage
Mayo 2020
The architecture of SARS-CoV-2 transcriptome
Dongwan Kim, Joo-Yeon Lee, Jeong-Sun Yang, Jun Won Kim, V. Narry Kim, Hyeshik Chang
Cell Press
Abril 2020
Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine
Wanbo Tai, Lei He, Xiujuan Zhang, Jing Pu, Denis Voronin, Shibo Jiang, Yusen Zhou & Lanying Du
Cellular & Molecular Immunology
Marzo 2020
